WASHINGTON, July 6, 2021 — The American Bar Association Antitrust Law Section has submitted comments in response to the Federal Trade Commission (FTC) Multilateral Pharmaceutical Merger Task Force’s request for public comments.
These views are presented only on behalf of the section. They have not been approved by the ABA House of Delegates or Board of Governors and should not be construed as representing the policy of the American Bar Association.
The cover letter and comments, dated June 25, 2021, are available for review online.
The ABA is the largest voluntary association of lawyers in the world. As the national voice of the legal profession, the ABA works to improve the administration of justice, promotes programs that assist lawyers and judges in their work, accredits law schools, provides continuing legal education, and works to build public understanding around the world of the importance of the rule of law. View our privacy statement online. Follow the latest ABA news at www.americanbar.org/news and on Twitter @ABANews.